Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma

References

1. 1.↵
   1. Barkovich AJ,
   2. Krischer J,
   3. Kun LE, et al

   . Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 1990;16:73–83 doi:10.1159/000120511 pmid:2132928

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Louis DN,
   2. Perry A,
   3. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
3. 3.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
4. 4.↵
   1. Varlet P,
   2. Baker SJ,
   3. Ellison DW, et al

   . Diffuse midline glioma, H3 K27-altered. In: WHO Classification of tumors editorial boards. WHO Classification of Tumours: Central Nervous System Tumours. 5th ed. IARC Press; 2021:69–73
5. 5.↵
   1. Hoffman LM,
   2. Veldhuijzen van Zanten SE,
   3. Colditz N, et al

   . Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG Registries. J Clin Oncol 2018;36:1963–72 doi:10.1200/JCO.2017.75.9308 pmid:29746225

   CrossRefPubMed
6. 6.↵
   1. Ostrom QT,
   2. Patil N,
   3. Cioffi G, et al

   . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol 2020;22:iv1–96 doi:10.1093/neuonc/noaa200 pmid:33123732

   CrossRefPubMed
7. 7.↵
   1. Leach JL,
   2. Roebker J,
   3. Schafer A, et al

   . MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. Neuro Oncol 2020;22:1647–57 doi:10.1093/neuonc/noaa140 pmid:32506137

   CrossRefPubMed
8. 8.↵
   1. Albright AL,
   2. Packer RJ,
   3. Zimmerman R, et al

   . Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 1993;33:1026–29; discussion 1029–30 doi:10.1227/00006123-199312000-00010 pmid:8133987

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Puget S,
   2. Beccaria K,
   3. Blauwblomme T, et al

   . Biopsy in a series of 130 pediatric diffuse intrinsic pontine gliomas. Childs Nerv Syst 2015;31:1773–80 doi:10.1007/s00381-015-2832-1 pmid:26351229

   CrossRefPubMed
10. 10.↵
    1. Wu G,
    2. Diaz AK,
    3. Paugh BS, et al

    . The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 2014;46:444–50 doi:10.1038/ng.2938 pmid:24705251

    CrossRefPubMed
11. 11.↵
    1. Gupta N,
    2. Goumnerova LC,
    3. Manley P, et al

    . Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol 2018;20:1547–55 doi:10.1093/neuonc/noy070 pmid:29741745

    CrossRefPubMed
12. 12.↵
    1. Calmon R,
    2. Dangouloff-Ros V,
    3. Varlet P, et al

    . Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features. Eur Radiol 2021;31:8913–24 doi:10.1007/s00330-021-07991-x pmid:34003354

    CrossRefPubMed
13. 13.↵
    1. Mackay A,
    2. Burford A,
    3. Carvalho D, et al

    . Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 2017;32:520–537.e5 doi:10.1016/j.ccell.2017.08.017 pmid:28966033

    CrossRefPubMed
14. 14.↵
    1. Kfoury-Beaumont N,
    2. Prakasam R,
    3. Pondugula S, et al

    . The H3K27M mutation alters stem cell growth, epigenetic regulation, and differentiation potential. BMC Biol 2022;20:124 doi:10.1186/s12915-022-01324-0 pmid:35637482

    CrossRefPubMed
15. 15.↵
    1. Lu VM,
    2. Power EA,
    3. Zhang L, et al

    . Liquid biopsy for diffuse intrinsic pontine glioma: an update. J Neurosurg Pediatr 2019 Sep 6. [Epub ahead of print] doi:10.3171/2019.6.PEDS19259 pmid:31491754

    CrossRefPubMed
16. 16.↵
    1. Azad TD,
    2. Jin MC,
    3. Bernhardt LJ, et al

    . Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. Neurosurg Focus 2020;48:E9 doi:10.3171/2019.9.FOCUS19699 pmid:31896079

    CrossRefPubMed
17. 17.↵
    1. Poussaint TY,
    2. Vajapeyam S,
    3. Ricci KI, et al

    . Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol 2016;18:725–34 doi:10.1093/neuonc/nov256 pmid:26487690

    CrossRefPubMed
18. 18.↵
    1. Aboian MS,
    2. Tong E,
    3. Solomon DA, et al

    . Diffusion characteristics of pediatric diffuse midline gliomas with histone H3-K27M mutation using apparent diffusion coefficient histogram analysis. AJNR Am J Neuroradiol 2019;40:1804–10 doi:10.3174/ajnr.A6302 pmid:31694820

    Abstract/FREE Full Text
19. 19.↵
    1. Zhang P,
    2. Duan Y,
    3. Gu G, et al

    . Clinical, pathological, and radiological features of 80 pediatric diffuse intrinsic pontine gliomas: a single-institute study. Front Oncol 2023;13:1007393 doi:10.3389/fonc.2023.1007393 pmid:36824137

    CrossRefPubMed
20. 20.↵
    1. Castel D,
    2. Philippe C,
    3. Calmon R, et al

    . Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 2015;130:815–27 doi:10.1007/s00401-015-1478-0 pmid:26399631

    CrossRefPubMed
21. 21.↵
    1. Castel D,
    2. Grill J,
    3. Debily MA

    . Histone H3 genotyping refines clinico-radiological diagnostic and prognostic criteria in DIPG. Acta Neuropathol 2016;131:795–96 doi:10.1007/s00401-016-1568-7 pmid:27038188

    CrossRefPubMed
22. 22.↵
    1. Piccardo A,
    2. Tortora D,
    3. Mascelli S, et al

    . Advanced MR imaging and ¹⁸F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas. Eur J Nucl Med Mol Imaging 2019;46:1685–94 doi:10.1007/s00259-019-04333-4 pmid:31030232

    CrossRefPubMed
23. 23.↵
    1. Lapin DH,
    2. Tsoli M,
    3. Ziegler DS

    . Genomic insights into diffuse intrinsic pontine glioma. Front Oncol 2017;7:57 doi:10.3389/fonc.2017.00057 pmid:28401062

    CrossRefPubMed
24. 24.↵
    1. Jaimes C,
    2. Vajapeyam S,
    3. Brown D, et al

    . MR imaging correlates for molecular and mutational analyses in children with diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 2020;41:874–81 doi:10.3174/ajnr.A6546 pmid:32381545

    Abstract/FREE Full Text
25. 25.↵
    1. Giagnacovo M,
    2. Antonelli M,
    3. Biassoni V, et al

    . Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG). Childs Nerv Syst 2020;36:697–704 doi:10.1007/s00381-019-04463-y pmid:31848724

    CrossRefPubMed
26. 26.↵
    1. Aboian MS,
    2. Solomon DA,
    3. Felton E, et al

    . Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. AJNR Am J Neuroradiol 2017;38:795–800 doi:10.3174/ajnr.A5076 pmid:28183840

    Abstract/FREE Full Text
27. 27.↵
    1. Khalid F,
    2. Goya-Outi J,
    3. Escobar T, et al

    . Multimodal MRI radiomic models to predict genomic mutations in diffuse intrinsic pontine glioma with missing imaging modalities. Front Med (Lausanne) 2023;10:1071447 doi:10.3389/fmed.2023.1071447 pmid:36910474

    CrossRefPubMed
28. 28.↵
    1. Chiang J,
    2. Diaz AK,
    3. Makepeace L, et al

    . Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. Acta Neuropathol Commun 2020;8:57 doi:10.1186/s40478-020-00930-9 pmid:32326973

    CrossRefPubMed
29. 29.↵
    1. Jenkinson M,
    2. Beckmann CF,
    3. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Schindelin J,
    2. Arganda-Carreras I,
    3. Frise E, et al

    . Fiji: an open-source platform for biological-image analysis. Nat Methods 2012;9:676–82 doi:10.1038/nmeth.2019 pmid:22743772

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Buczkowicz P,
    2. Hawkins C

    . Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma. Front Oncol 2015;5:147 doi:10.3389/fonc.2015.00147 pmid:26175967

    CrossRefPubMed
32. 32.↵
    1. Khuong-Quang DA,
    2. Buczkowicz P,
    3. Rakopoulos P, et al

    . K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 2012;124:439–47 doi:10.1007/s00401-012-0998-0 pmid:22661320

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Wu G,
    2. Broniscer A,
    3. McEachron TA, et al

    ; St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012;44:251–53 doi:10.1038/ng.1102 pmid:22286216

    CrossRefPubMed
34. 34.↵
    1. Koral K,
    2. Mathis D,
    3. Gimi B, et al

    . Common pediatric cerebellar tumors: correlation between cell densities and apparent diffusion coefficient metrics. Radiology 2013;268:532–37 doi:10.1148/radiol.13121362 pmid:23564715

    CrossRefPubMed
35. 35.↵
    1. Gauvain KM,
    2. McKinstry RC,
    3. Mukherjee P, et al

    . Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 2001;177:449–54 doi:10.2214/ajr.177.2.1770449 pmid:11461881

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Chenevert TL,
    2. Ross BD

    . Diffusion imaging for therapy response assessment of brain tumor. Neuroimaging Clin N Am 2009;19:559–71 doi:10.1016/j.nic.2009.08.009 pmid:19959005

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Chen HJ,
    2. Panigrahy A,
    3. Dhall G, et al

    . Apparent diffusion and fractional anisotropy of diffuse intrinsic brain stem gliomas. AJNR Am J Neuroradiol 2010;31:1879–85 doi:10.3174/ajnr.A2179 pmid:20595371

    Abstract/FREE Full Text
38. 38.↵
    1. Castel D,
    2. Kergrohen T,
    3. Tauziède-Espariat A, et al

    . Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation. Acta Neuropathol 2020;139:1109–13 doi:10.1007/s00401-020-02142-w pmid:32193787

    CrossRefPubMed
39. 39.↵
    1. Merhemic Z,
    2. Imsirovic B,
    3. Bilalovic N, et al

    . Apparent diffusion coefficient reproducibility in brain tumors measured on 1.5 and 3 T clinical scanners: a pilot study. Eur J Radiol 2018;108:249–53 doi:10.1016/j.ejrad.2018.10.010 pmid:30396664

    CrossRefPubMed
40. 40.↵
    1. Mulkern RV,
    2. Ricci KI,
    3. Vajapeyam S, et al

    . Pediatric brain tumor consortium multisite assessment of apparent diffusion coefficient z-axis variation assessed with an ice-water phantom. Acad Radiol 2015;22:363–69 doi:10.1016/j.acra.2014.10.006 pmid:25435183

    CrossRefPubMed
41. 41.↵
    1. Wagner MW,
    2. Namdar K,
    3. Napoleone M, et al

    . Radiomic features based on MRI predict progression-free survival in pediatric diffuse midline glioma/diffuse intrinsic pontine glioma. Can Assoc Radiol J 2023;74:119–26 doi:10.1177/08465371221109921 pmid:35768942

    CrossRefPubMed